{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:05:29Z","timestamp":1773921929146,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2004,6,22]],"date-time":"2004-06-22T00:00:00Z","timestamp":1087862400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1038\/sj.bjc.6601955","type":"journal-article","created":{"date-parts":[[2004,6,22]],"date-time":"2004-06-22T15:13:06Z","timestamp":1087917186000},"page":"225-232","source":"Crossref","is-referenced-by-count":17,"title":["Establishing long-term survival and cure in young patients with Ewing's sarcoma"],"prefix":"10.1038","volume":"91","author":[{"name":"on behalf of UKCCSG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C L","family":"Weston","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A W","family":"Craft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I J","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Machin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,6,22]]},"reference":[{"key":"BF6601955_CR1","first-page":"143","volume":"4","author":"V Bramwell","year":"1985","unstructured":"Bramwell V, Mouridsen H, Santoro A, Blackledge G, Somers R, Thomas D, Sylvester R, Bush H (1985) Cyclophosphamide vs Ifosfamide: a randomised phase II trial in adult soft tissue sarcoma. Preliminary report of EORTC soft tissue and bone group. Proc ASCO 4: 143 (abstract)","journal-title":"Proc ASCO"},{"key":"BF6601955_CR2","first-page":"733","volume":"3","author":"AW Craft","year":"1985","unstructured":"Craft AW (1985) Controversies in the management of bone tumours. Cancer Surv 3: 733\u2013750","journal-title":"Cancer Surv"},{"key":"BF6601955_CR3","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/S0959-8049(97)00043-9","volume":"33","author":"AW Craft","year":"1997","unstructured":"Craft AW, Cotterill SJ, Bullimore JA, Pearson D (1997) Long-term results from the first UKCCSG Ewing's Tumour Study (ET-1). United Kingdom Children's Cancer Study Group (UKCCSG) and the Medical Research Council Bone Sarcoma Working Party. Eur J Cancer 33: 1061\u20131069","journal-title":"Eur J Cancer"},{"key":"BF6601955_CR4","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.1200\/JCO.1998.16.11.3628","volume":"16","author":"AW Craft","year":"1998","unstructured":"Craft AW, Cotterill S, Malcolm A, Spooner D, Grimer R, Souhami R, Imeson J, Leiws I (1998) Ifosfamide-containing chemotherapy in Ewing's sarcoma: The Second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's Tumour Study. J Clin Oncol 16: 3628\u20133633","journal-title":"J Clin Oncol"},{"key":"BF6601955_CR5","first-page":"717","volume":"13","author":"F Demeocq","year":"1984","unstructured":"Demeocq F, Carton P, Patte C, Oberlin O, Sarrazin D, Lemerle J (1984) Treatment of Ewing's sarcoma with intensive initial chemotherapy. 1st evaluation of a French pediatric multicenter protocol. Presse Med 13: 717\u2013721","journal-title":"Presse Med"},{"key":"BF6601955_CR6","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1002\/1097-0142(19800415)45:8<2213::AID-CNCR2820450834>3.0.CO;2-L","volume":"45","author":"DL Glaubiger","year":"1980","unstructured":"Glaubiger DL, Makuch R, Schwarz J, Levine A, Johnson RE (1980) Determination of prognostic factors and their influence on therapeutic results in patients with Ewing's sarcoma. Cancer 45: 2213\u20132219","journal-title":"Cancer"},{"issue":"Suppl","key":"BF6601955_CR7","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1007\/BF02579891","volume":"111","author":"V Gobel","year":"1986","unstructured":"Gobel V, J\u00fcrgens H, Etsp\u00fcler G, Exner U, K\u00fchl J, Ritter J, Winkler K, Gobel U (1986) Effectiveness of ifosfamide alone and in combination with cisplatinum in patients with recurrent Ewing's sarcoma. Cancer Res Clin Oncol 111(Suppl): S30","journal-title":"Cancer Res Clin Oncol"},{"key":"BF6601955_CR8","first-page":"1","volume":"XXI","author":"DR Jones","year":"1981","unstructured":"Jones DR, Powles RL, Machin D, Sylvester RJ (1981) On estimating the proportion of cured patients in clinical studies. Biometrie-Praximetrie XXI: 1\u201311","journal-title":"Biometrie-Praximetrie"},{"key":"BF6601955_CR9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1055\/s-2008-1033973","volume":"197","author":"H Jurgens","year":"1985","unstructured":"Jurgens H, Gobel V, Michaelis J, Ramach W, Ritter J, Sauer R, Treuner J, Voute PA, Winkler K, Gobel U, Lewis RJ, Marcove RC, Rosen G (1985) The Cooperative Ewing Sarcoma Study CESS 81 of the German Pediatric Oncology Society \u2013 analysis after 4 years. Klin Padiatr 197: 225\u2013232","journal-title":"Klin Padiatr"},{"issue":"Suppl 2","key":"BF6601955_CR10","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1007\/BF00647446","volume":"18","author":"I Magrath","year":"1986","unstructured":"Magrath I, Sandlund J, Raynor A, Rosenberg S, Arasi V, Miser J (1986) A phase II study of ifosfamide in the treatment of recurrent sarcomas in young people. Cancer Chemother Pharmacol 18(Suppl 2): S25\u2013S28","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF6601955_CR11","first-page":"174","volume":"26","author":"ME Nesbit","year":"1976","unstructured":"Nesbit ME (1976) Ewing's sarcoma. Ca: Cancer J Clin 26: 174\u2013180","journal-title":"Ca: Cancer J Clin"},{"key":"BF6601955_CR12","first-page":"255","volume":"56","author":"ME Nesbit","year":"1981","unstructured":"Nesbit ME, Perez CA, Tefft M, Burgert EO, Vietti TJ, Kissane J, Pritchard DJ, Gehan EA (1981) Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: an Intergroup Study. Monogr Natl Cancer Inst 56: 255\u2013262","journal-title":"Monogr Natl Cancer Inst"},{"key":"BF6601955_CR13","volume-title":"Survival Analysis: A Practical Approach","author":"MKB Parmar","year":"1995","unstructured":"Parmar MKB, Machin D (1995) Survival Analysis: A Practical Approach. Chichester, UK: Wiley"},{"key":"BF6601955_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/bjc.1977.1","volume":"35","author":"R Peto","year":"1977","unstructured":"Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patients. II analysis and examples. Br J Cancer 35: 1\u201339","journal-title":"Br J Cancer"},{"key":"BF6601955_CR15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/1097-0142(197501)35:1<36::AID-CNCR2820350106>3.0.CO;2-L","volume":"35","author":"TC Pomeroy","year":"1975","unstructured":"Pomeroy TC, Johnson RE (1975) Combined modality therapy of Ewing's sarcoma. Cancer 35: 36\u201347","journal-title":"Cancer"},{"key":"BF6601955_CR16","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/1097-0142(197402)33:2<384::AID-CNCR2820330213>3.0.CO;2-T","volume":"33","author":"G Rosen","year":"1974","unstructured":"Rosen G, Wollner N, Tan C, Wu SJ, Hajdu SI, Cham W, D'Angio GJ, Murphy ML (1974) Proceedings: disease-free survival in children with Ewing's sarcoma treated with radiation therapy and adjuvant four-drug sequential chemotherapy. Cancer 33: 384\u2013393","journal-title":"Cancer"},{"key":"BF6601955_CR17","unstructured":"SAS (2001) SAS release 8.02 SAS Institute Inc."},{"key":"BF6601955_CR18","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/sim.987","volume":"21","author":"R Sposto","year":"2002","unstructured":"Sposto R (2002) Cure model analysis in cancer: an application to data from the Children's Cancer Group. Stat Med 21: 293\u2013312","journal-title":"Stat Med"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6601955.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6601955","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6601955.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T08:09:54Z","timestamp":1684397394000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6601955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6,22]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["BF6601955"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6601955","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,6,22]]}}}